Submission of Voting Results for the EGM held on 3rd June, 2025 at 03:02 PM through VC/OAVM.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Evoq Remedies held an Extra-Ordinary General Meeting on 3rd June 2025 via video conferencing, where all 5 resolutions were passed with 100% approval and no votes against. Key items approved include an increase in authorised share capital, two preferential allotments of equity shares (one in which promoters are interested), an alteration of the object clause of the Memorandum of Association, and the regularization of Ms. Pushpa Joshi as a Non-Executive Independent Director. Out of 1,703 shareholders on record date (27 May 2025), 5 promoter group members and 14 public shareholders attended; total votes polled were 28.08 lakh shares, representing just 11.28% of the 2.49 crore outstanding shares. Promoters voted with nearly all their 27.92 lakh shares, while only 16,000 public shares (0.07% of public holdings) participated in e-voting.
Shareholders have cleared the way for a preferential share issuance and a possible expansion in the company's permitted business activities, which could lead to equity dilution. Public participation was extremely thin, so the resolutions effectively reflect promoter-driven decisions rather than broad shareholder endorsement.